Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
BioRestorative Therapies ( (BRTX) ) has shared an announcement.
BioRestorative Therapies, a regenerative medicine company, announced promising developments in their stem cell-based therapies, reporting financial progress and a provisional license for processing non-autologous donor tissue. The company shared advancements in their BRTX-100 clinical trials for lumbar disc disease and their ThermoStem program aimed at metabolic disorders, while also noting increased revenue from BioCosmeceutical products. With no outstanding debt and a strong financial position, BioRestorative is poised for continued growth in the innovative stem cell therapy market.
For an in-depth examination of BRTX stock, go to TipRanks’ Stock Analysis page.